Posts by vgn1
SARS-CoV-2 Transmission To, From, and Among Children: What’s New?
SARS-CoV-2 Transmission To, From, and Among Children: What’s New? April 30, 2021 The dynamics of infection of children has been of great interest, particularly as it pertains to the issue of whether or not to open schools and to vaccinate children. The discussions have at times been contentious. There are multiple aspects to the issue.…
Read MoreUnderstanding Multisystem Inflammatory Syndrome in Children with COVID-19
Understanding Multisystem Inflammatory Syndrome in Children with COVID-19 April 16, 2021 Multisystem inflammatory syndrome in children (MIS-C) is a rare but is severe hyperinflammatory condition in children and adolescents. It is also known as pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. This typically occurs 2–6 weeks after acute SARS-CoV-2 infection. Symptoms include persistent fever,…
Read MoreCOVID-19 Vaccine for Long-Haulers: A Surprising Benefit?
COVID-19 Vaccine for Long-Haulers: A Surprising Benefit? April 9, 2021 We are in the COVID-19 pandemic over one year now and still learning something new about SARS-CoV-2 and COVID-19. One of the serious and mysterious aspects of COVID-19 is long-term symptoms that persist for a significant period after SARS-CoV-2 infection as previously discussed. Many patients…
Read MoreGlobal Virus Network (GVN) Announces Eight Distinguished International Appointments to Board of Directors
World Leaders in Business, Science, Law, Industry, Philanthropy & Government Are Committed to Supporting the GVN Baltimore, MD, USA (April 6, 2021) – The Global Virus Network (GVN), a coalition of the world’s leading medical virology research centers working together to prevent illness and death from viral disease, today announced the election of eight distinguished…
Read MoreA Statement From the Leadership of the Global Virus Network on the Passing of Dr. John Martin
An Outstanding Clinical Scientist, A Dedicated Humanitarian, An Astute Businessman, An Effective Global Leader, and A True Friend Baltimore, MD, April 1, 2021: The Global Virus Network, the world’s leading coalition of virologists combatting current and emerging pandemic viral threats and viral causes of disease through international collaborative research response, mourns the passing of its good friend…
Read MoreGlobal Virus Network (GVN) Catalyzes World Health Organization (WHO) to Officially Recognize HTLV-1 as Threatening Pathogen to Humans
March 29, 2021 During GVN’s 9th International Meeting in Melbourne, Australia on September 25-27, 2017 in partnership with the Peter Doherty Institute and the Institut Pasteur, researchers held impressive sessions on one of the most potent human carcinogens, human T cell leukemia virus-1 (HTLV-1). The sessions were organized by Dr. Sharon Lewin, Director of The…
Read MoreCorrelates of Protection
Role of Correlates of Protection, or Immune Measurements, in Predicting Protective Immunity of COVID-19 Vaccines March 29, 2021 Broadly speaking, correlates of protection are measurements of immune parameters that allow prediction of the degree of protection against infection or disease induced by a pathogen. A prime point of interest in consideration of protection against SARS-CoV-2…
Read MoreGLOBAL VIRUS NETWORK (GVN) ADDS SANOFI PASTEUR TO GVN HEALTHCARE & PHARMA CENTERS OF EXCELLENCE COALITION
The Partnership Focuses on Training The Next Generation of Virus Researchers to Safeguard Mankind from Current and Future Threats Baltimore, Maryland, USA, March 23, 2021: The Global Virus Network (“GVN”), the world’s leading coalition of virologists combatting current and emerging pandemic viral threats and viral causes of disease through international collaborative research response, by training…
Read MoreGlobal Virus Network (GVN) Adds Renowned Institut Pasteur Korea (IPK) to Combat Viral Diseases
Baltimore, Maryland, USA, March 22, 2021: The Global Virus Network (GVN), representing 62 Centers of Excellence and 11 Affiliates in 34 countries comprising foremost experts in every class of virus causing disease in humans, and the Institut Pasteur Korea (IPK) announced today the addition of the IPK as GVN’s newest Center of Excellence. “We are…
Read MorePregnancy and COVID-19 Vaccines
Pregnancy and COVID-19 Vaccines March 5, 2021 While the COVID-19 vaccination program is extending globally, we have many questions regarding the vaccines’ safety, durability, and efficacy against variants. One of the important safety questions is the effects of COVID-19 vaccines on pregnant women as clinical trials for COVID-19 vaccines were conducted without their participation. Are…
Read More